Validity of self-reports of return for routine repeat screening in an Ovarian Cancer Screening Program

Cancer Epidemiology Biomarkers and Prevention

Volumn 16, Issue 3, 2007, Pages 490-493

  Lykins, Emily L B ^a   Pavlik, Edward L ^a   Andrykowski, Michael A ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RISK; CANCER SCREENING; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; OVARY CANCER; PRIORITY JOURNAL; SELF REPORT; TRANSVAGINAL ECHOGRAPHY; VALIDITY;

FEMALE; HUMANS; INTERVIEWS; KENTUCKY; MASS SCREENING; MIDDLE AGED; MULTIVARIATE ANALYSIS; OVARIAN NEOPLASMS; PATIENT COMPLIANCE; PREDICTIVE VALUE OF TESTS; SELF DISCLOSURE; SENSITIVITY AND SPECIFICITY;

EID: 34047243808     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-06-0433     Document Type: Article

References (28)

1. American Cancer Society. Cancer facts and figures 2005. Atlanta (GA): American Cancer Society; 2005.
2. Ries LAG, Eisner MP, Kosary CL, et al., editors. SEER cancer statistics review, 1975-2002. National Cancer Institute, Bethesda, MD. Based on November 2004 SEER data submission, posted to the SEER Web site 2005. Available from: (http://seer.cancer.gov/csr/1975_2002/.
3. Rosenthal A, Jacobs I. Ovarian cancer screening. Semin Oncol 1998;25: 315-25.
4. Bell R, Petticrew M, Luengo S, Sheldon TA. Screening for ovarian cancer: a systematic review. Health Technol Assess 1998;2:1-84.
5. Einhorn N, Sjovall K, Knapp RC, et al. Prospective evaluation of serum CA-125 levels for early detection of ovarian cancer. Obstet Gynecol 1992; 80:14-8.
6. Jacobs IJ, Skates SJ, MacDonald N, et al. Screening for ovarian cancer: a pilot randomized controlled trial. Lancet 1999;353:1207-10.
7. Sato S, Yokoyama Y, Sakamoto T, Futagami M, Saito Y. Usefulness of mass screening for ovarian carcinoma using transvaginal sonography. Cancer 2000;89:582-8.
8. Skates SJ, Menon U, MacDonald N, et al. Calculation of the risk of ovarian cancer from serial CA-125 values for women at risk for ovarian cancer. J Clin Oncol 2003;21:206-10S.
9. van Nagell JR, Jr., DePriest PD, Reedy MB, et al. The efficacy of transvaginal sonographic screening in asymptomatic women at risk for ovarian cancer. Gynecol Oncol 2000;77:350-6.
10. Kramer BS, Gohagan J, Prorok PC, Smart C. A National Cancer Institute sponsored trial for prostatic, lung, colorectal, and ovarian cancer. Cancer 1993;71:589-93.
11. U.S. Preventive Services Task Force. Screening for ovarian cancer: recommendation statement. Am Fam Physician 2005;71:759-62.
12. Ferrini R. Screening asymptomatic women for ovarian cancer: American College of Preventive Medicine practice policy. Am J Prev Med 1997;13: 444-6.
13. Banks SM, Salovey P, Greener S, et al. The effects of message framing of mammography utilization. Health Psychol 1995;14:178-84.
14. Schwartz MD, Rimer BK, Daly M, Sands C, Lerman C. A randomized trial of breast cancer risk counseling: the impact on self-reported mammography use. Am J Public Health 1999;89:924-6.
15. Marcus AC, Mason M, Wolfe P, et al. The efficacy of tailored print materials in promoting colorectal cancer screening: results from a randomized trial involving callers to the national cancer institute's cancer information service. J Health Commun 2005;10:83-104.
16. Navarro AM, Senn K, McNicholas LJ, et al. Por La Vida model intervention enhances use of cancer screening tests among Latinos. Am J Prev Med 1998; 15:32-41.
17. Sirovich BE, Schwartz LM, Woloshin S. Screening men for prostate and colorectal cancer in the United States. Does practice reflect the evidence? JAMA 2003;289:1414-20.
18. Baier M, Calonge N, Cutter G, et al. Validity of self-reported colorectal cancer screening behavior. Cancer Epidemiol Biomarkers Prev 2000;9: 229-32.
19. Paskett ED, Tatum CM, Mack DW, et al. Validation of self-reported breast and cervical cancer screening tests among low income minority women. Cancer Epidemiol Biomarkers Prev 1996;5:721-6.
20. King ES, Rimer BK, Trock B, Balshem A, Engstrom P. How valid are mammography self-reports? Am J Public Health 1990;80:1386-8.
21. Gordon NP, Hiatt RA, Lampert DI. Concordance of self-reported data and medical record audit for six cancer screening procedures. J Natl Cancer Inst 1993;85:566-70.
22. Champion VL, Menon U, McQuillen DH, Scott C. Validity of self-reported mammography in low-income African-American women. Am J Prev Med 1998;14:111-7.
23. Caplan LS, McQueen DV, Qualter JR, et al. Validity of women's self-reports of cancer screening test utilization in a managed care population. Cancer Epidemiol Biomarkers Prev 2003;12:1182-7.
24. DePriest PD, DeSimone CP. Ultrasound screening for the early detection of ovarian cancer. J Clin Oncol 2003;21:194-9s.
25. Salsman JM, Pavlik E, Boerner L, Andrykowski MA. Clinical, demographic, and psychological characteristics of new, asymptomatic participants in a transvaginal ultrasound screening program for ovarian cancer. Prev Med 2004;39:315-22.
26. Andrykowski MA, Boerner LM, Salsman JM, Pavlik E. Psychological response to test results in an ovarian cancer screening program: A longitudinal study. Health Psychol 2004;23:622-30.
27. Vernon SW, Briss PA, Tiro JA, Warnecke RB. Some methodologic lessons learned from cancer screening research. Cancer 2004;101:1131-45.
28. Harper R, Reeves B. Reporting of precision of estimates for diagnostic accuracy: a review. BMJ 1999;318:1322-3.